Antibody-Mediated Encephalitis.
Josep Dalmau, Francesc Graus
https://pubmed.ncbi.nlm.nih.gov/29490181/Actively Recruiting
Led by Third Affiliated Hospital, Sun Yat-Sen University · Updated on 2026-06-17
100
Participants Needed
1
Research Sites
12 weeks
Total Duration
Neuroimmune diseases such as neuromyelitis optica spectrum disorders, multiple sclerosis, autoimmune encephalitis, myasthenia gravis, Guillain-Barr syndrome, and myelin oligodendrocyte glycoprotein antibody-associated disease are more common among women of reproductive age and may affect fertility. This study aims to generate detailed clinical data on pregnancy-associated autoimmune diseases to help clinicians optimize disease management during reproductive years. It includes a prospective epidemiological design with a planned follow-up period of up to five years and future extensions for up to ten years. The study includes two groups women with neuroimmune diseases who have plans for pregnancy and age-matched healthy women planning pregnancy as controls. Participants are recruited from specialized outpatient clinics at the Third Affiliated Hospital, Sun Yat-sen University. Researchers collect data on relapse frequency, symptoms, imaging findings, treatment, blood profiles, and disability scores. Maternal drug levels, postpartum relapse rates, and neonatal development are also closely monitored during and after pregnancy. Participants will undergo assessments including neurological disability scales, visual function tests, blood and cerebrospinal fluid biomarkers, imaging scans, and questionnaires at multiple timepoints before, during, and up to one year after delivery. Pregnancy outcomes, neonatal health measures, and maternal complications are recorded. The study tracks these outcomes over a total period of up to 25 months per participant, with ongoing long-term monitoring planned. This comprehensive approach aims to improve understanding of disease management during pregnancy and postpartum in women with neuroimmune disorders.
CONDITIONS
Cohort Study on Neuroimmune Diseases in the Reproductive Age
W
Wei Qiu, Ph.D
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Third Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 25 months
Participants are monitored before, during, and after pregnancy with clinical evaluations, imaging, blood tests, and questionnaires. Both patient and healthy control groups are assessed for disease activity and pregnancy outcomes.
Multiple visits at pre-pregnancy, each trimester, and postpartum up to 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Josep Dalmau, Francesc Graus
https://pubmed.ncbi.nlm.nih.gov/29490181/Luis D Pacheco, Antonio F Saad, Gary D V Hankins...
https://pubmed.ncbi.nlm.nih.gov/27741183/De-Cai Tian, Zixiao Li, Meng Yuan...
https://pubmed.ncbi.nlm.nih.gov/34327375/Nils Erik Gilhus, Socrates Tzartos, Amelia Evoli...
https://pubmed.ncbi.nlm.nih.gov/31048702/Hugh J Willison, Bart C Jacobs, Pieter A van Doorn
https://pubmed.ncbi.nlm.nih.gov/26948435/Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero...
https://pubmed.ncbi.nlm.nih.gov/35196927/Kristen M Krysko, Ruth Dobson, Raed Alroughani...
https://pubmed.ncbi.nlm.nih.gov/36931808/Pamela A McCombe
https://pubmed.ncbi.nlm.nih.gov/35354378/Nils Erik Gilhus, Jan J Verschuuren
https://pubmed.ncbi.nlm.nih.gov/26376969/Axel Petzold, Clare L Fraser, Mathias Abegg...
https://pubmed.ncbi.nlm.nih.gov/36179757/Third Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor